Myeloid sarcoma: current approach and therapeutic options
نویسندگان
چکیده
منابع مشابه
Myeloid Sarcoma Presenting with Lateral Cervical Mass and Eosinophilia; a Diagnostic and Therapeutic Dilemma: Case Report
Myeloid sarcoma is a rare extramedullary tumor of immature myeloid cells. It has been very rarely reported as lateral cervical mass in English literature. Myeloid sarcoma has also been reported with marked eosinophilia. Here we present a 17 year old boy with lateral cervical mass and persistent eosinophilia. The mass was isointense in MRI and homogenously enhanced after contrast injection which...
متن کاملCurrent therapeutic options in psoriasis
Introduction Psoriasis is a chronic skin disorder, characterized by inflammatory and hyperproliferative processes. Globally, reports on the prevalence of psoriasis reveal major differences in terms of ethnicity and climate zone, ranging between 0 and 11.8% (Jacobson et al 2011). In Europe, psoriasis affects approximately 2-3% of the population. Psoriasis onset can occur at any age, including bi...
متن کاملPrimary myelofibrosis: current therapeutic options
Primary myelofibrosis is a Philadelphia-negative myeloproliferative neoplasm characterized by clonal myeloid expansion, followed by progressive fibrous connective tissue deposition in the bone marrow, resulting in bone marrow failure. Clonal evolution can also occur, with an increased risk of transformation to acute myeloid leukemia. In addition, disabling constitutional symptoms secondary to t...
متن کاملNovel therapeutic options in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a biologically complex and molecularly and clinically heterogeneous disease, and its incidence is increasing as the population ages. Cytogenetic anomalies and mutation testing remain important prognostic tools for tailoring treatment after induction therapy. Despite major advances in understanding the genetic landscape of AML and its impact on the pathophysiology...
متن کاملChronic myeloid leukemia: current treatment options.
The choice of primary treatment for patients with chronic myeloid leukemia (CML) diagnosed in chronic phase has become exceedingly difficult. There is little doubt that allogeneic stem cell transplantation can eradicate the leukemia and that a graft-versus-leukemia effect makes a major contribution to this result; conversely, only a minority of patients are eligible for transplantation, which s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Therapeutic Advances in Hematology
سال: 2011
ISSN: 2040-6207,2040-6215
DOI: 10.1177/2040620711410774